LWM
TMDX icon

Laidlaw Wealth Management’s Transmedics TMDX Stock Holding History

Laidlaw Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,250
Closed -$301K – 275
2021
Q1 		$301K Buy
+7,250
New +$223K 0.1% 166

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Laidlaw Wealth Management's TMDX Position: Q2 2021 in Review

Laidlaw Wealth Management sold out of Transmedics (TMDX) in Q2 2021, closing a stake of 7,250 shares — an estimated $301K sold.

Laidlaw Wealth Management first reported a position in TMDX in Q1 2021 and held it in 1 quarter. The position peaked at $301K in Q1 2021. 124 funds tracked by Wall St. Rank hold TMDX as of Q2 2021.

  • Laidlaw Wealth Management reported no remaining Transmedics position as of Q2 2021 after selling out during the quarter.
  • Laidlaw Wealth Management sold 7,250 Transmedics shares in Q2 2021, an estimated $301K.
  • Laidlaw Wealth Management first reported a position in Transmedics in Q1 2021 and held it in 1 quarter.
  • Laidlaw Wealth Management's Transmedics position peaked at $301K in Q1 2021.
  • 124 funds tracked by Wall St. Rank held Transmedics as of Q2 2021.

Based on Laidlaw Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.